AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

NRSN · NASDAQ · Biotechnology

NeuroSense Therapeutics (NRSN)

Develops PrimeC, a fixed-dose combination therapy for ALS.

$0.4240

Pre-market−0.00 (−0.21%)

At close$0.4249(+1.14%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

	Institutions13 holders · as of Mar 31, 2026	≥ 1.07%	379.7K ADS
	Otherremainder	≤ 98.93%	34.97M ADS

35.35M ADS as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count is from the company's Dec 2023 annual report; nothing newer is on file here.

The share count has not been confirmed by a second filing; stakes use it as it stands.

Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.

Institutional filings for NRSNW are not on file here, so the institutional figure is a floor.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Yorkville Advisors Global, LPInstitution	0.22%	78,000 ADS	13Fas of Mar 31, 2026
Independent Advisor AllianceInstitution	0.14%	50,000 ADS	13Fas of Mar 31, 2026
UBS Group AGInstitution	0.14%	49,096 ADS	13Fas of Mar 31, 2026
Two Sigma Investments, LPInstitution	0.13%	44,445 ADS	13Fas of Mar 31, 2026
Meitav Investment House LtdInstitution	0.11%	40,000 ADS	13Fas of Mar 31, 2026
Jane Street Group, LLCInstitution	0.08%	28,670 ADS	13Fas of Mar 31, 2026
Commonwealth Equity Services, LLCInstitution	0.06%	22,775 ADS	13Fas of Mar 31, 2026
PNC Financial Services Group, Inc.Institution	0.06%	21,150 ADS	13Fas of Mar 31, 2026
Pathstone Holdings, LLCInstitution	0.05%	16,528 ADS	13Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution	0.04%	15,870 ADS	13Fas of Mar 31, 2026
Creative PlanningInstitution	0.03%	11,911 ADS	13Fas of Mar 31, 2026
Jones Financial Companies LLLPInstitution	0.00%	1,000 ADS	13Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution	0.00%	265 ADS	13Fas of Mar 31, 2026
Abir RavehInsider	—9.99% of class, as filed	—	13Gfiled Dec 9, 2024 ↗
Alon Ben-Noon¹Insiderofficer: Chief Executive Officer	—27.42% of class, as filed	—	13Gfiled Dec 23, 2021 ↗
Hagit Binder¹Insiderofficer: General Manager	—	—	Form 4filed Mar 30, 2026 ↗
Cary J. Claiborne¹Insiderdirector	—	—	Form 4filed Mar 18, 2026 ↗
E Europe LimitedStrategic	—5.51% of class, as filed	—	13Gfiled Dec 30, 2021 ↗
Or Eisenberg¹Insiderofficer: Chief Financial Officer	—	—	Form 4filed Jun 17, 2026 ↗
Roy Golan¹Insiderdirector	—	—	Form 4filed Mar 18, 2026 ↗
Gordon.Insider	—9.48% of class, as filed	—	13Gfiled Dec 20, 2021 ↗
Mark Leuchtenberger¹Insiderdirector	—	—	Form 4filed Mar 18, 2026 ↗
Revital Mandil-Levin¹Insiderdirector	—	—	Form 4filed Mar 31, 2026 ↗
Christine A. Pellizzari¹Insiderdirector	—	—	Form 4filed Mar 18, 2026 ↗
Real Property International LimitedStrategic	—3.84% of class, as filed	—	13Gfiled Mar 15, 2023 ↗

This position is filed in underlying shares, not receipts; the ratio is unknown, so no percentage.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

13 holders · 379.7K shares · 3 new positions · 4 increased · 3 reduced · 3 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Yorkville Advisors Global, LP	78.0K	0.22%	−22.0K	May 13, 2026
Independent Advisor Alliance	50.0K	0.14%	+50.0Knew	May 12, 2026
UBS Group AG	49.1K	0.14%	+18.2K	May 5, 2026
Two Sigma Investments, LP	44.4K	0.13%	−7.1K	May 15, 2026
Meitav Investment House Ltd	40.0K	0.11%	0	Apr 29, 2026
Jane Street Group, LLC	28.7K	0.08%	+28.7Knew	May 12, 2026
Commonwealth Equity Services, LLC	22.8K	0.06%	0	Apr 27, 2026
PNC Financial Services Group, Inc.	21.2K	0.06%	+21.2Knew	May 8, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Abir Ravehincl. Rimon Gold Assets Ltd., Goldfinger Trust	9.99%	2.30M	13G	Dec 9, 2024 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Jun 16, 2026	Or Eisenbergofficer: Chief Financial Officer	Purchase	250,000	$0.8000	1,504,050
Jun 16, 2026	Alon Ben-Noonofficer: Chief Executive Officer	Purchase	250,000	$0.8000	4,534,233

CongressHouse and Senate disclosures

Not reported.